Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kawashima, M.
Right arrow Articles by Itai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawashima, M.
Right arrow Articles by Itai, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 31:195-202 (2001)
© 2001 Foundation for Promotion of Cancer Research

Influence of Postsurgical Residual Tumor Volume on Local Control in Radiotherapy for Maxillary Sinus Cancer

Mitsuhiko Kawashima1, Takashi Ogino1, Ryuichi Hayashi2, Satoshi Ishikura1, Keiji Nihei1, Yoshinori Ito1, Hiroshi Ikeda1, Satoshi Ebihara2 and Yuji Itai3,+,§

Departments of 1Radiology and 2Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Chiba and 3Department of Radiology, University of Tsukuba, Tsukuba, Ibaraki, Japan

Background: The aim was to study the influence of postsurgical gross residual tumor volume on local control of maxillary sinus cancer treated with radiotherapy combined with debulking surgery.

Methods: Forty-three patients who underwent combined surgery and radiotherapy (50–72 Gy, median 60 Gy) for squamous cell carcinoma of the maxillary sinus were reviewed. Gross residual tumor volume (GRTV) after surgery was measured on computed tomograms obtained during the radiotherapy planning. Patients were classified according to GRTV as follows: group AA, GRTV = 0 (microscopic residual, n = 2); group A, GRTV <10 cm3 (n = 24); group B, 10–40 cm3 (n = 9); and group C, >=40 cm3 (n = 8). The relationship between local control and GRTV was analyzed using univariate and multivariate analysis.

Results: The 2-year local control rate for all patients was 62%. The differences in local control rates between groups AA, A and B were not significant (P > 0.05), but the rate was significantly lower in group C than in the other groups (69% at 2 years vs 31% at 1 year, P < 0.001). Multivariate analysis showed that GRTV (P = 0.002) and histological differentiation (poorly differentiated histology was favorable, P = 0.035) were independent prognostic factors and that intra-arterial chemotherapy and administered total dose were not. Local control in groups A and B significantly depended on the total dose of radiotherapy, with 2-year control rates of patients receiving 50 Gy (n = 6) and >=60 Gy (n = 27) of 17% vs 79%, respectively (P < 0.001).

Conclusions: Our data suggest that adequate, not complete, debulking associated with a total radiotherapy dose of >=60 Gy can provide satisfactory local control for patients with squamous cell carcinoma of the maxillary sinus.

+ For reprints and all correspondence: Mitsuhiko Kawashima, Department of Radiology, National Cancer Center Hospital East, 6–5–1 Kashiwanoha, Kashiwa, 277-8577 Chiba, Japan. E-mail: mkawashi@east.ncc.go.jp

§ Abbreviations: RT, radiotherapy; IAC, intra-arterial chemotherapy; GRTV, gross residual tumor volume; CT, computed tomography; MRI, magnetic resonance imaging; LFS, local recurrence-free survival; DSS, disease-specific survival


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.